AETERNA ZENTARIS INC
AETERNA ZENTARIS INC
Share · CA0079755017 · AEZS (XTSE)
Overview Financial Indicators
No Price
n/a

Performance

Jour Semaine Mois 3 mois 6 mois 1 an 5 ans
- - - - -3,37 % -13,29 % -94,01 %

Profil de l'entreprise pour AETERNA ZENTARIS INC Action

Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests. Its lead product is macimorelin, an orally available peptidomimetic ghrelin receptor (GHSR-1a) agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a for the diagnosis of adult growth hormone deficiency and childhood-onset growth hormone deficiency, as well as oncology indications. The company markets macimorelin under the Macrilen brand name. Aeterna Zentaris Inc. has a license agreement with University Wuerzburg to research, develop, manufacture, and sell a potential COVID-19 vaccine; development, manufacture, and commercialization of the treatment for neuromyelitis optica spectrum disorder; and to develop human 3D intestinal tissue models to study infection biology; and for pre-clinical development towards the potential treatment of Parkinson's disease. It also has a license agreement with Consilient Health Ltd., Novo Nordisk Novo Nordisk Health Care AG, and NK MEDITECH Ltd. for the development and commercialization of macimorelin in the United States and Canada, as well as The University of Sheffield, the United Kingdom for the research, development, manufacture, and commercialization of parathyroid hormone fusion polypeptides for the treatment of primary hypoparathyroidism. Aeterna Zentaris Inc. was incorporated in 1990 and is headquartered in Summerville, South Carolina.

Données de l'entreprise

Nom AETERNA ZENTARIS INC
Société Aeterna Zentaris Inc.
Symbole AEZS
Site web https://www.zentaris.com
Marché d'origine XTSE TSX
ISIN CA0079755017
Type de titre Action
Secteur Healthcare
Industrie Biotechnology
PDG Mr. Gilles R. Gagnon ICD.D, M.B.A., M.Sc.
Capitalisation boursière 18 Mio
Pays États-Unis d'Amérique
Devise CAD
Employés 0,0 T
Adresse 315 Sigma Drive, 29486 Summerville
Date d'introduction en bourse 2000-05-10

Changements d'identifiant

Date De À
01.07.2004 AELA AEZS

Symboles boursiers

Nom Symbole
NASDAQ AEZS

Autres actions

Les investisseurs qui détiennent AETERNA ZENTARIS INC ont également les actions suivantes dans leur portefeuille :
AMPEGA GLOBAL AKTIENFONDS
AMPEGA GLOBAL AKTIENFONDS Fonds
LB.HESS.THR.CARRARA04A/18
LB.HESS.THR.CARRARA04A/18 Obligation
La plateforme financière MoneyPeak suit et analyse les investissements et les portefeuilles. Du dépôt de titres à l'achat de crypto.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.
Mentions légales Protection des données Blog Communauté Retour d'information Changelog
Im App Store herunterladen Bei Google Play herunterladen
Tous droits réservés © LCP GmbH 2025